Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Platelet-rich plasma can temporarily inhibit some drug-resistant bacteria in diabetic foot infections.

Apremilast showed mixed results for treating severe alopecia areata.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Etanercept effectively treated a severe skin condition when other treatments failed.

PRP gel may be slightly more effective than phenytoin cream for healing diabetic foot ulcers.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Human insulin via microinfusion may effectively improve atrophic acne scars.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.